Cantitate/Preț
Produs

Neuropsychiatric Symptoms of Movement Disorders: Neuropsychiatric Symptoms of Neurological Disease

Editat de Heinz Reichmann
en Limba Engleză Hardback – 21 oct 2014
This is an up-to-date, comprehensive review of the neuropsychiatry of patients with movement disorders, i.e. Parkinson’s disease, Huntington’s disease, dystonia and others, by active authorities in the field, with an emphasis on diagnostic and management issues.
This book includes critical appraisal of the methodological aspects and limitations of the current research on the neuropsychiatry of movement disorders and on unanswered questions/controversies. Symptomatology and pharmacological aspects of management are discussed, to provide robust information on drug dosages, side effects and interaction, in order to enable the reader to manage these patients more safely. Illustrative cases provide real life scenarios that are clinically relevant and engaging to read.
Neuropsychiatric Symptoms of Movement Disorders is aimed at neurologists, movement disorder specialists and psychiatrists and will also be of interest to intensive care doctors, psychologists and neuropsychologists, research and specialist nurses, clinical researchers and methodologists.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 99661 lei  43-57 zile
  Springer International Publishing – 22 sep 2016 99661 lei  43-57 zile
Hardback (1) 125448 lei  43-57 zile
  Springer International Publishing – 21 oct 2014 125448 lei  43-57 zile

Din seria Neuropsychiatric Symptoms of Neurological Disease

Preț: 125448 lei

Preț vechi: 132050 lei
-5% Nou

Puncte Express: 1882

Preț estimativ în valută:
24011 25025$ 19988£

Carte tipărită la comandă

Livrare economică 06-20 ianuarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783319095363
ISBN-10: 3319095366
Pagini: 299
Ilustrații: XIII, 299 p. 5 illus., 3 illus. in color.
Dimensiuni: 155 x 235 x 20 mm
Greutate: 0.62 kg
Ediția:2015
Editura: Springer International Publishing
Colecția Springer
Seria Neuropsychiatric Symptoms of Neurological Disease

Locul publicării:Cham, Switzerland

Public țintă

Professional/practitioner

Cuprins

Depression, Apathy, Anhedonia, Fatigue in Parkinson’s Disease.- Mild Cognitive Impairment in Parkinson’s Disease.- Parkinson’s Disease Dementia.- Impulse Control Disorders.- Influence of Dietary Constituents on Motor and Non-Motor Symptoms in Parkinson’s Disease.- Psychosis in Parkinson’s Disease.- Neuropsychiatric Manifestations in Atypical Parkinsonian Syndromes.- Neuropsychiatric Disturbances in Dystonia.- Depression in Huntington’s Disease.- Cognitive Impairment and Dementia (Mild or Major Neurocognitive Disorder) in Huntington’s Disease.- Tics.- Wilson’s Disease.- Ataxia.

Recenzii

“This book provides a much needed review of the latest clinical recommendations on the diagnosis and treatment of the mood, cognitive, and behavioral abnormalities seen in these disorders. … This is a valuable resource for clinicians who treat patients with movement disorders. … It also provides useful strategies that can assist clinicians with choosing appropriate pharmacological therapies, subsequent medication monitoring, and patient counseling, while thoroughly examining the evidence guiding these recommendations.” (Melissa Jones, Doody's Book Reviews, June, 2015)

Notă biografică

Heinz Reichmann MD PhD graduated from the University of Freiburg, Germany in 1979. He spent the following four years as a research fellow at the Institute for Biochemistry, University of Konstanz, Germany and the Institute of Neurology, Columbia University, USA. This was paid for by honorary grants for excellency to Dr. Reichmann. He returned to Germany where he held a number of positions at the University of Würzburg, becoming Professor of Neurology in 1990. In 1996, he was appointed Chairman of the Department of Neurology at the University of Dresden, where he is now also Dean of the Medical Faculty.
Heinz Reichmann is a member of numerous scientific societies including the German Neurological Society, the European Neurological Society, the American Academy of Neurology, the Royal Society of Medicine and the Movement Disorder Society. In addition, Dr Reichmann serves on the editorial boards for a number of prestigious neurology journals. His major research interests are energy metabolism, neuroprotection, premotor symptoms in Parkinson’s disease, etiopathogenesis and treatment in PD. He serves on many Neurological Boards and was President of the German Parkinson Society and the German Muscle Society. In 2009 Professor Reichmann started his 2-year term as President of the German Neurological Society. He is Past-President of the European Neurological Society and has helped to initiate the new European Academy of Neurology, starting from 2014.

Textul de pe ultima copertă

This is an up-to-date, comprehensive review of the neuropsychiatry of patients with movement disorders, i.e. Parkinson’s disease, Huntington’s disease, dystonia and others, by active authorities in the field, with an emphasis on diagnostic and management issues. 
This book includes critical appraisal of the methodological aspects and limitations of the current research on the neuropsychiatry of movement disorders and on unanswered questions/controversies. Symptomatology and pharmacological aspects of management are discussed, to provide robust information on drug dosages, side effects and interaction, in order to enable the reader to manage these patients more safely. Illustrative cases provide real life scenarios that are clinically relevant and engaging to read. 
Neuropsychiatric Symptoms of Movement Disorders is aimed at neurologists, movement disorder specialists and psychiatrists, and will also be of interest to intensive care doctors, psychologists and neuropsychologists, research and specialist nurses, clinical researchers and methodologists.​

Caracteristici

Discusses neuropsychiatric complications in movement disorders, which are of increasing interest as an indicator of outcome Comprehensive discussion by experts in the field internationally Provides an overview of new drugs available that may be useful in the management of patients with neuropsychiatric problems and movement disorders